Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HuMAB companies -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (601)	1/6/2004 9:19:41 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 1022

I followed Ingene (acquired 1989) closely, as the founders were friends and one was on my thesis committee. You want to look for inventor Randy Robinson, I believe. I searched quickly, is this it?..... patft.uspto.gov Not certain, but I believe that Dr. Robinson is at PDLI now? If so, you could call and ask. :-)

To: nigel bates who wrote (601)	1/6/2004 10:14:28 AM
From: Icebrg	Respond to of 1022

Diversa and Xoma. Diversa seems eager to cover as many bases as possible. Just a couple of months ago they agreed to be courted by Medarex. Erik Diversa and Medarex Form Strategic Partnership for Antibody Engineering SAN DIEGO, and PRINCETON, N.J., Oct. 16 /PRNewswire-FirstCall/ -- Diversa Corporation (Nasdaq: DVSA) and Medarex, Inc. (Nasdaq: MEDX) today announced that they have entered into a strategic partnership aimed at developing antibodies with enhanced functionality. Through a joint research effort, Diversa and Medarex plan to combine their respective capabilities in directed evolution and antibody biology. The companies are co-sponsoring this project, and they believe it may have broad applicability in the field of therapeutic antibodies.